Back to companies

Syngene International Ltd: Premium Databases

Syngene International Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

A sample of Syngene International Insights data

Headline Published Journalists
Showing 3 of 3 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore 15 Nov 2016 Lorem
Sun BioPharma works with CROs Novotech and Courante Oncology for pancreatic cancer trial, seeks USD 5m-USD 10m and partners - CEO 15 Nov 2016 Fiona Barry
Calypso Biotech seeks EUR 17m Series A by YE14, will hire CROs and CMOs - CEO 05 Feb 2014 Natalie Morrison
Motif aims for USD 5m raise to advance MRSA candidate to IND readiness - CEO 28 Jan 2014 Casey McDonald
Insights

Feature

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Benefit

Drug Insights:

  • Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
  • Material intelligence on competitors, including breaking news
  • Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Value

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Premium databases is part of our industry range of products

Gain a 360-degree view of Syngene International Ltd and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code